The Priority Review

Tag

Carbetocin

1 story

  1. Clinical trials

    ACADIA posts results of Phase 3 carbetocin nasal spray trial in Prader-Willi syndrome

    The study, completed in August 2025, enrolled 175 participants and evaluated carbetocin nasal spray versus placebo over 12 weeks. Results were first posted on ClinicalTrials.gov on October 15, 2026.